TPO is required to pass order before the last date of limitation period of 60 days: ITAT
- News|Blog|Transfer Pricing|
- 2 Min Read
- By Taxmann
- |
- Last Updated on 6 September, 2022
Case Details: Sigma Aldrich Chemicals (P.) Ltd. v. DCIT - [2022] 141 taxmann.com 431 (Bangalore-Trib.)
Judiciary and Counsel Details
-
- George George K, Judicial Member & Ms Padmavathy S, Accountant Member
- Tata Krishna, Adv. for the Appellant.
- Sumer Singh Meena, CIT-DR for the Respondent.
Facts of the Case
The assessee had entered into international transactions with its Associate Enterprises (AEs) and the matter was referred to the TPO for determination of Arm’s Length Price (ALP).
The TPO passed orders under section 92CA on 30-1-2014 and 30-1-2015 for assessment years 2010-2011 and 2011-2012, respectively. According to the assessee, the TPO ought to have passed orders on or before 29-1-2014 and 29-1-2015 for assessment years 2010-2011 and 2011-2012, respectively. However, the orders were passed beyond the prescribed time limit.
ITAT Held
The Tribunal held that from the perusal of section 92CA(3A), it can be seen that the TPO can pass an order at any time before 60 days prior to the due date under section 153 for passing the assessment order.
Accordingly, the due date for passing the assessment order for assessment year 2010-2011 is 31-3-2014 and assessment year 2011-2012 is 31-3-2015. Thus, TPO to pass the transfer pricing orders for should be at any time before 30-1-2014 and 30-1-2015, i.e., on or before 29-1-2014 and 29-1-2015.
In the given case, the TPO had passed the transfer pricing order on 30-1-2014 and 30-1-2015, i.e., beyond the prescribed time limit. Hence, the same is barred by limitation in terms of section 92CA(3A) read with section 153.
List of Cases Referred to
-
- Dy. CIT v. Pfizer Healthcare India (P.) Ltd. [2022] 137 taxmann.com 215/444 ITR 636 (Mad.)(para 3)
- Dy. CIT v. Tata Power Solar Systems Ltd. [2022] 140 taxmann.com 272 (Bang. – Trib.) (para 3)
- Swiss Re Global Business Solution India (P.) Ltd. v. Dy. CIT [2022] 138 taxmann.com 418 (Bang. – Trib.) (para 3)
- ECL Finance Ltd. v. ACIT [IT Appeal No. 899 (Mum.) of 2018, dated 22-9-2021] (para 3)
- Pfizer Healthcare India (P.) Ltd. v. Jt. CIT [2021] 124 taxmann.com 536/433 ITR 28 (Mad.) (para 7)
- Sigma Aldrich Chemicals (P.) Ltd. v. Dy. CIT [2021] 123 taxmann.com 398/187 ITD 374 (Bang. – Trib.) (para 13).
Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.
Taxmann Publications has a dedicated in-house Research & Editorial Team. This team consists of a team of Chartered Accountants, Company Secretaries, and Lawyers. This team works under the guidance and supervision of editor-in-chief Mr Rakesh Bhargava.
The Research and Editorial Team is responsible for developing reliable and accurate content for the readers. The team follows the six-sigma approach to achieve the benchmark of zero error in its publications and research platforms. The team ensures that the following publication guidelines are thoroughly followed while developing the content:
- The statutory material is obtained only from the authorized and reliable sources
- All the latest developments in the judicial and legislative fields are covered
- Prepare the analytical write-ups on current, controversial, and important issues to help the readers to understand the concept and its implications
- Every content published by Taxmann is complete, accurate and lucid
- All evidence-based statements are supported with proper reference to Section, Circular No., Notification No. or citations
- The golden rules of grammar, style and consistency are thoroughly followed
- Font and size that’s easy to read and remain consistent across all imprint and digital publications are applied